Literature DB >> 9191521

Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis.

H Uozaki1, H Horiuchi, T Ishida, T Iijima, T Imamura, R Machinami.   

Abstract

BACKGROUND: The prognosis for patients with osteosarcoma has improved over the past 20 years, mainly due to developments in chemotherapy. Some proteins have been reported to show drug resistance. Theoretically, overexpression of some of these proteins makes treatment difficult, leading to poorer outcome.
METHODS: Specimens taken from conventional osteosarcomas of the extremity bones from 60 patients younger than 30 years were used. In all cases, preoperative oncostatic chemotherapy was undertaken after biopsy. If available, biopsy specimens were also used for sequential comparison. Among resistance-related proteins, expression of metallothioneins (MTs), glutathione-S-transferase pi (GST pi), heat shock protein 27 (Hsp27), and lung resistance-related protein (LRP) was evaluated immunohistochemically in paraffin sections. The log rank test was used for univariate analysis and the Cox regression model for multivariate analysis.
RESULTS: At biopsy, only overexpression of Hsp27 was associated with poor prognosis. At surgery, a relationship was observed between poor prognosis and overexpression of GST pi, Hsp27, and LRP. Groups overexpressing one protein tended to overexpress another. Overexpression of these proteins in surgical specimens also correlated with histologic response to preoperative chemotherapy and clinical stage. In multivariate analysis, Hsp27 overexpression at biopsy was an independent prognostic factor.
CONCLUSIONS: Inherent overexpression of Hsp27 is independently related to poor outcome in osteosarcoma patients. Overexpression of GST pi, Hsp27, and LRP at surgery might be associated with failure of preoperative chemotherapy. Control of the expression of these proteins may improve the outcome for patients with osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191521     DOI: 10.1002/(sici)1097-0142(19970615)79:12<2336::aid-cncr7>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  29 in total

Review 1.  Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.

Authors:  Suoyuan Li; Wei Sun; Hongsheng Wang; Dongqing Zuo; Yingqi Hua; Zhengdong Cai
Journal:  Tumour Biol       Date:  2015-02-11

2.  Downregulated expression of HSP27 in human low-grade glioma tissues discovered by a quantitative proteomic analysis.

Authors:  Guobo Shen; Shufang Liang; Zhizhong Xu; Liangxue Zhou; Shiyin Xiao; Xiangying Xia; Ronghui Li; Ying Liao; Chao You; Yuquan Wei
Journal:  Proteome Sci       Date:  2010-03-26       Impact factor: 2.480

3.  Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients.

Authors:  J Andrew Livingston; Wei-Lien Wang; Jen-Wei Tsai; Alexander J Lazar; Cheuk Hong Leung; Heather Lin; Shailesh Advani; Najat Daw; Janice Santiago-O'Farrill; Mario Hollomon; Nancy B Gordon; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2018-03-28       Impact factor: 6.261

4.  Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis.

Authors:  T Kashima; J Kawaguchi; S Takeshita; M Kuroda; M Takanashi; H Horiuchi; T Imamura; Y Ishikawa; T Ishida; S Mori; R Machinami; A Kudo
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Using yeast two-hybrid system to identify ECRG2 associated proteins and their possible interactions with ECRG2 gene.

Authors:  Yong-Ping Cui; Jian-Bo Wang; Xin-Yu Zhang; Mei-Xia Bi; Li-Ping Guo; Shih-Hsin Lu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  Metallothionein expression in hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Lian-Yue Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Human osteosarcoma xenografts and their sensitivity to chemotherapy.

Authors:  Skjalg Bruheim; Oyvind S Bruland; Knut Breistol; Gunhild M Maelandsmo; Oystein Fodstad
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

8.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

9.  Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin.

Authors:  A Gaumann; D S Tews; T Mentzel; P K Petrow; E Mayer; M Otto; C J Kirkpatrick; J Kriegsmann
Journal:  Virchows Arch       Date:  2003-05-13       Impact factor: 4.064

10.  Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.

Authors:  Gayathri T Selvarajah; Jolle Kirpensteijn; Monique E van Wolferen; Nagesha A S Rao; Hille Fieten; Jan A Mol
Journal:  Mol Cancer       Date:  2009-09-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.